Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a

Monika Pogorzelska1, Patricia W Stone, Elaine L Larson

  • 1Columbia University School of Nursing, New York, NY 10032, USA. Mp2422@columbia.edu

Abstract

Insights

Adoption of multidrug-resistant organism (MDRO) screening and infection control policies in intensive care units (ICUs) varied widely in 2008. Predictors for implementation were identified, but further research is needed to optimize strategies.

Area of Science:

  • Infectious Diseases
  • Healthcare Epidemiology
  • Public Health

Background:

  • Multidrug-resistant organisms (MDROs) pose a significant threat in healthcare settings.
  • Intensive care units (ICUs) are high-risk environments for MDRO transmission.
  • Standardized screening and infection control policies are crucial for managing MDROs.

Purpose of the Study:

  • To describe the adoption of MDRO screening and infection control policies in US ICUs in 2008.
  • To identify factors predicting the presence, monitoring, and implementation of these policies.
  • To understand variations in policy adoption across different hospital settings.

Main Methods:

  • A national survey of infection control directors in hospitals participating in the National Healthcare Safety Network was conducted in 2008.
  • A modified Dillman technique was used for survey administration.
  • Bivariate and multivariable logistic regression models were employed to analyze policy differences and identify predictors.

Main Results:

  • A 57% response rate was achieved with 250 hospitals participating.
  • Routine screening for specific MDROs varied: MRSA (59%), VRE (22%), gram-negative rods (12%), and C. difficile (11%).
  • Reported ICU policies included screening all admissions (40%), periodic screening (27%), presumptive isolation (31%), and patient cohorting (42%).
  • Hospital characteristics, such as mandatory reporting and teaching status, were independent predictors of policy implementation.

Conclusions:

  • Significant variation exists in the adoption and implementation of MDRO screening and infection control interventions in ICUs.
  • Discrepancies may stem from differing interpretations of published guidelines.
  • Further research is essential to develop effective strategies and promote compliance with infection control measures.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...